Advertisement
Table 1 Main demographic and clinical features of the study group
| Variables | p-value (n = 68) | |
|---|---|---|
| Age, years (median IQR) | 39 (25–59) | |
| Gender | ||
| Male, n. pts (%) | 31 (45) | 0. 6 |
| Female, n. pts (%) | 37 (55) | |
| Anti AchR Ab, nmol/L (median IQR) | 3.1 (2.0-4.0) | |
| Score MG (median IQR) | 23 (14–29) | |
| Symptom duration | ||
| &<12 months, n. pts (%) | 20 (29) | 0.69 |
| &12 months, n. pts (%) | 48 (71) | |
| Oropharyngeal symptoms | ||
| &Yes, n. pts (%) | 36 (53) | 0.91 |
| &No, n. pts (%) | 32 (47) | |
| MGFA classification | ||
| &Class I, n. pts (%) | 6 (9) | 0.06 |
| &Class II, n. pts (%) | 40 (59) | |
| &Class III, n. pts (%) | 22 (32) | |
| Histology | ||
| &Hyperplasia, n. pts (%) | 27 (40) | 0.89 |
| &Atrophia, n. pts (%) | 23 (34) | |
| &Normal, n. pts (%) | 18 (26) | |
| Thymic germinal centers, n. pts (%) | 33 (48) | |
| &Ectopic tissue, n. pts (%) | 37 (54) | |
| &Ectopic germinal centers, n. pts (%) | 23 (34) |
